OCT retinal nerve fiber layer thickness differentiates acute optic neuritis from MOG antibody-associated disease and Multiple Sclerosis

References

Page 1

	Year	Citations
Index for rating diagnostic tests W. J. Youden Cancer ReliabilityIndex SystemEngineeringEvaluation MeasureDiagnostic Criterion	1950	11.1K
A Randomized, Controlled Trial of Corticosteroids in the Treatment of Acute Optic Neuritis Roy W. Beck, Patricia A. Cleary, Malcolm M. Anderson, New England Journal of Medicine	1992	1.3K
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome Journal of Neuroinflammation	2016	873
Clinical presentation and prognosis in MOG-antibody disease: a UK study Maciej Juryńczyk, Silvia Messina, Mark Woodhall, Brain Neurological DisorderImmunodeficienciesImmunologyDiagnosisPathology	2017	704
The OSCAR-IB Consensus Criteria for Retinal OCT Quality Assessment Prejaas Tewarie, Lisanne J. Balk, Fiona Costello, PLoS ONE	2012	580
Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination Sudarshini Ramanathan, Shekeeb S. Mohammad, Esther Tantsis, Journal of Neurology Neurosurgery & Psychiatry	2017	548
Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults Álvaro Cobo‐Calvo, Anne Ruiz, Élisabeth Maillart, Neurology	2018	508
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin Journal of Neuroinflammation	2016	421
The APOSTEL recommendations for reporting quantitative optical coherence tomography studies Andrés Cruz-Herranz, Lisanne J. Balk, Timm Oberwahrenbrock, Neurology	2016	399
Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG–Associated Disorders A. Sebastian López‐Chiriboga, Masoud Majed, James P. Fryer, JAMA Neurology	2018	398

Page 1